Category: New products
-
Crispr Diagnostics Company Launches with $35M Funding
Sherlock Biosciences Inc., a new enterprise offering medical diagnostics based on the genome-editing technology Crispr, is starting up with $35 million in seed financing.
-
Antibacterial Sleeve Protects Against Implant Infections
A mesh envelope infused with antibiotics holding an implanted cardiac device is shown in a large-scale clinical trial to reduce the number of infections associated with those devices.
-
Infographic – Public, Tech Execs Differ on A.I. Use
The Edelman public relations agency released results of a survey earlier this month gauging the public’s awareness of A.I., with some of those findings displayed yesterday by our friends at Statista.
-
Mobile Device Screens That Tap Back
Engineers in Germany designed screens for mobile phones and tablets that not only feel touch pressure, but can also return pulses or vibrations to users’ fingers.
-
NIH Funding Nanodrugs to Prevent Opioid Addiction
A drug that invokes the immune system to block addictive effects of opioid pain drugs and heroin is in early development at Washington University in St. Louis.
-
Spin-Off Producing Commercial-Grade Graphene
A company based on university lab research in the U.K. says it’s producing graphene, a promising carbon-based material, in quality and scale for electronics.
-
Genomics, A.I. Calculate Immune Health
An international team designed a technique to gauge a person’s immune system age and health, by analyzing genomic and cellular indicators with machine-learning algorithms.
-
Trial Shows Engineered Plant Product Heals Wounds
A small-scale clinical trial shows synthetic human collagen derived from engineered tobacco plants promotes closure of lower-limb wounds, often difficult to heal.
-
Infographic – Mobile Internet Costs Worldwide
Our friends at Statista provide an indication of the cost paid by consumers for transmitting those data over the mobile internet in many countries of the world.
-
Univ. Developing Implanted Islet Cell Bags for Diabetes
Implantable collections of insulin-producing islet cells resembling tea bags, for people with type 1 diabetes, are being developed by researchers at University of Arizona.